Industry News
Pharmaceutical Industry News
Former F.D.A. Commissioners Sound Alarm on Plan to Change Vaccine Policy
Twelve former commissioners, in a New England Journal of Medicine article, said they were “deeply concerned” by a leaked memo from the agency’s vaccine regulator.
Cosmo Pharmaceuticals has revealed…
Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone could become a game-changing treatment for male-pattern hair loss.
A federal appeals court has…
A federal appeals court has overturned a previous ruling out of Texas that required Daiichi to pay $41.8 million in Enhertu royalties, plus an 8% running royalty rate, to its former ADC partner, Seagen.
Johnson & Johnson has teamed…
Johnson & Johnson has teamed up with Naomi Watts to put a clearer focus on vision health, leveraging the actor’s star power to encourage women over 40 to make eye exams part of their self-care
The highly anticipated Adept-2…
The highly anticipated Adept-2 study data will not read out by year-end as previously planned after BMS identified “irregularities due to clinical trial execution at a small number of study sites,” the company said Wednesday.
Excelsior Sciences, which spun out…
Excelsior Sciences, which spun out of investment firm Deerfield Management, has roped in $95 million to scale its chemical synthesis "smart bloccs" platform, invest in its internal pipeline and forge partnerships across the industry, including
A Ferring Pharmaceuticals survey…
A Ferring Pharmaceuticals survey has found 39% of people undergoing fertility treatment are at least considering leaving their jobs, leading the drugmaker to question whether companies are doing enough to support employees.
Tuesday, the European Council…
Tuesday, the European Council gathered behind new regulations that seek to diversify local biopharma supply chains, support collaborative drug procurement models and devise incentives to bolster drug production in the bloc.
Incyte is strutting its stuff to…
Incyte is strutting its stuff to boost awareness and support for people with vitiligo—with help from supermodel Winnie Harlow.
The U.S. House of Representatives…
The U.S. House of Representatives has given a unanimous thumbs up to the Give Kids A Chance Act, which would revive the FDA’s rare pediatric review voucher program following its expiration in December of last
The manufacturing center of…
The manufacturing center of excellence, proposed in a recent congressional bill, would boost innovation and train workers to bolster production talent throughout the industry.
Could Weight Loss Drugs Turn Fat Cats Into Svelte Ozempets?
GLP-1 drugs for pets could be the next frontier for the blockbuster weight loss and diabetes drugs.
Even as moving tariff targets and…
Even as moving tariff targets and a capricious market have injected uncertainty into the operations of many biopharma players this year, it’s hard to deny the effect that President Donald Trump’s trade duties have had
To Avoid Pharma Tariffs, U.K. Agrees to Trump’s Demand to Pay More for Drugs
President Trump has complained that wealthy countries like Britain pay too little for drugs, leading America to bear much of the burden of the costs of medicines.
The CDC’s vaccine advisory…
The CDC's vaccine advisory committee will meet later this week with a newly promoted chairman in outspoken mRNA critic Kirk Milhoan, M.D., Ph.D., as former chair Martin Kulldorff, Ph.D., moves to a new role in
The lawsuit filed Monday…
The lawsuit filed Monday underscores substantial burdens the one-year test would impose on providers and describes the pilot's rollout as "textbook disregard of administrative law."
The burgeoning field of…
The burgeoning field of transthyretin amyloid cardiomyopathy, which spurred excitement over a potential $20 billion market, may have just revealed the first indication of a slowdown.
Mitsubishi Tanabe Pharma has…
Mitsubishi Tanabe Pharma has undergone a rebrand. Following a 510 billion Japanese yen ($3.3 billion) takeover by Bain Capital, the 350-year-old company has dropped Mitsubishi from its name and those of its affiliates.
Microsize, a U.S.-based CDMO that…
Microsize, a U.S.-based CDMO that specializes in particle size reduction and control technologies, has linked with Switzerland’s Schedio Group to acquire a Lonza micronization facility for an undisclosed price.
Almost exactly a year after…
Almost exactly a year after Omnicom and Interpublic Group announced their plans to merge into the world’s largest advertising agency, their combination is complete.